Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Related Articles by Review for PubMed (Select 11192474)

1.
2.

Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.

DeVane CL, Nemeroff CB.

Clin Pharmacokinet. 2001;40(7):509-22. Review.

PMID:
11510628
3.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
4.

Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor.

Dostert P, Benedetti MS, Poggesi I.

Eur Neuropsychopharmacol. 1997 Apr;7 Suppl 1:S23-35; discussion S71-3. Review.

PMID:
9169308
5.

Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.

McEnroe JD, Fleishaker JC.

Clin Pharmacokinet. 2005;44(3):237-46. Review.

PMID:
15762767
6.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
7.

Clinical pharmacokinetics of mizolastine.

Lebrun-Vignes B, Diquet B, Chosidow O.

Clin Pharmacokinet. 2001;40(7):501-7. Review.

PMID:
11510627
8.

Clinical pharmacokinetics of mirtazapine.

Timmer CJ, Sitsen JM, Delbressine LP.

Clin Pharmacokinet. 2000 Jun;38(6):461-74. Review.

PMID:
10885584
9.

Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression.

Scates AC, Doraiswamy PM.

Ann Pharmacother. 2000 Nov;34(11):1302-12. Review.

PMID:
11098346
10.
11.

The clinical pharmacokinetics of escitalopram.

Rao N.

Clin Pharmacokinet. 2007;46(4):281-90. Review.

PMID:
17375980
12.

Vigabatrin. Clinical pharmacokinetics.

Rey E, Pons G, Olive G.

Clin Pharmacokinet. 1992 Oct;23(4):267-78. Review.

PMID:
1395360
13.

Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.

DeVane CL, Gill HS.

J Clin Psychiatry. 1997;58 Suppl 5:7-14. Review.

PMID:
9184622
14.

Clinical pharmacokinetics and pharmacodynamics of linagliptin.

Graefe-Mody U, Retlich S, Friedrich C.

Clin Pharmacokinet. 2012 Jul 1;51(7):411-27. doi: 10.2165/11630900-000000000-00000. Review.

PMID:
22568694
15.

Clinical pharmacology of axitinib.

Chen Y, Tortorici MA, Garrett M, Hee B, Klamerus KJ, Pithavala YK.

Clin Pharmacokinet. 2013 Sep;52(9):713-25. doi: 10.1007/s40262-013-0068-3. Review.

PMID:
23677771
16.

Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

He YL.

Clin Pharmacokinet. 2012 Mar 1;51(3):147-62. doi: 10.2165/11598080-000000000-00000. Review.

PMID:
22339447
17.

A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.

Faessel HM, Obach RS, Rollema H, Ravva P, Williams KE, Burstein AH.

Clin Pharmacokinet. 2010 Dec;49(12):799-816. doi: 10.2165/11537850-000000000-00000. Review.

PMID:
21053991
18.

Overview of the pharmacokinetics of fluvoxamine.

van Harten J.

Clin Pharmacokinet. 1995;29 Suppl 1:1-9. Review.

PMID:
8846617
19.

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

Swainston Harrison T, Perry CM.

Drugs. 2004;64(15):1715-36. Review.

PMID:
15257633
20.

Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

Schwab M, Klotz U.

Clin Pharmacokinet. 2001;40(10):723-51. Review.

PMID:
11707060
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk